• Products
  • Video
  • Events
  • News
  • Landing
  • Pages

Simone Volpi named President and Managing Director of Comecer

We will consolidate our global presence in primary packaging for pharmaceuticals and radiopharmaceuticals while remaining a key local player“.


Simone Volpi has been named President and Managing Director of Comecer Group, a leader in the design and manufacture of isolation equipment and systems for the pharmaceutical and nuclear medicine sectors.

Mr. Volpi has over 28 years of international experience, spanning different industrial sectors. Before joining Comecer, he was Vice President of Engineered Valves for Circor International. He also acquired leadership experience at Tyco International and Pentair, including as Global Business Director for the Actuation sector. Mr. Volpi also has multi-year experience in the motor industry and fluids control sector.

“I join an enthusiastic and highly skilled team, aware of the role Comecer plays in improving people’s health thanks to the development of its technology,” noted Mr. Volpi. “We will continue to provide innovative and customised solutions, so as to further consolidate our global presence in primary packaging for pharmaceuticals and radiopharmaceuticals.”

Mr. Volpi succeeds Alessia Zanelli who served the company with distinction since 2009. Comecer was established in 1975 by the Zanelli family.

The decision to appoint Mr. Volpi reflects Comecer’s transition from a family-owned business into a corporate enterprise within ATS, a multinational market leader. ATS provides automation solutions to many of the world’s most successful companies, spanning multiple sectors. With a market capitalization in excess of $4 billion, ATS’ shares trade on the Toronto Stock Exchange. The Canadian multinational became the parent company of Comecer in 2019.



About Comecer

Comecer develops and produces systems and equipment for containment and management in aseptic and shielded environments for the production of pharmaceuticals, radiopharmaceuticals, stem cell storage, and treatment. Active as a provider of technologies in the Pharmaceutical and Nuclear Medicine sectors, it specialises in isolation systems for regenerative medicine and tissue engineering. Comecer technology is applied in hospitals, universities, research institutes, pharmaceutical companies, and large industrial groups all over the globe.

Founded in 1975, Comecer today employs 355 qualified professionals. Headquartered in Castel Bolognese, Italy, the company has sales and service locations in North America, Europe, and Asia. Comecer became part of Canadian multinational ATS in 2019.


About ATS

ATS is an industry-leading automation solutions provider to many of the world’s most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products, and value-added services, including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, food & beverage, transportation, consumer products, and energy. Founded in 1978, ATS employs over 5,000 people at 28 manufacturing facilities and over 50 offices in North America, Europe, Southeast Asia, and China. The Company’s shares are traded on the Toronto Stock Exchange under the symbol ATA.

Visit the Company’s website at

Have questions?


I have read and understood the information notice pursuant to Art. 13 GDPR (Information notice – Privacy Policy)